Apolipoprotein A-IV levels and phenotype distribution in NIDDM

Area of Science:

• Endocrinology and Metabolism
• Lipidology
• Cardiovascular Disease Research

Background:

• Non-insulin-dependent diabetes mellitus (NIDDM) is often associated with dyslipidemia, impacting cardiovascular risk.
• Apolipoprotein A-IV (apoA-IV) plays a role in lipid metabolism, but its association with NIDDM and specific phenotypes requires further elucidation.

Purpose of the Study:

• To determine plasma apoA-IV levels and phenotype distribution in NIDDM patients.
• To analyze the influence of apoA-IV phenotype on lipid profiles within the NIDDM population.

Main Methods:

• Measurement of total cholesterol, triglycerides, HDL cholesterol (HDL2 and HDL3 subfractions), free fatty acids, and apoA-IV levels.
• Analysis conducted on 83 NIDDM patients and 100 normal control subjects.
• Determination of apoA-IV phenotype for all participants.

Main Results:

• NIDDM patients exhibited significantly higher triglyceride and free fatty acid levels, and lower HDL and HDL2 cholesterol levels compared to controls.
• Plasma apoA-IV levels were significantly higher in both male and female NIDDM patients versus controls.
• In controls, the apoA-IV-1-2 phenotype was linked to higher HDL and HDL2 cholesterol, a protective association absent in NIDDM patients.

Conclusions:

• Elevated plasma apoA-IV in NIDDM is primarily associated with hypertriglyceridemia and secondarily with HDL cholesterol levels.
• The apoA-IV phenotype distribution did not differ between NIDDM patients and controls.
• The metabolic dysregulation in NIDDM appears to abolish the potential cardioprotective lipid profile associated with the apoA-IV-1-2 phenotype.